Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Other Investing Activities
Investing cash flows not reported separately.
Other Investing Activities history
Currency unavailable · from the cash flow
No Other Investing Activities data reported for this period type.
Other Investing Activities vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 220.2M SEK | +15728.2% | — | 16556.9% |
| LTM Mar 2026 | $10M USD | — | — | 2.8% | |
| LTM Mar 2026 | $50K USD | -100.9% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | +6.7% | 0.0% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +7813.7% | +6.7% | 1.4% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.